Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,198,000 | 10,850,000 | 5,360,000 | 14,532,000 | 7,548,000 |
| Marketable Securities | N/A | N/A | 7,841,000 | N/A | N/A |
| Receivables | 7,142,000 | 6,883,000 | 6,648,000 | 6,813,000 | 6,233,000 |
| Inventories | 6,450,000 | 6,241,000 | 5,455,000 | 5,268,000 | 5,022,000 |
| Other current assets | 2,295,000 | 2,313,000 | 2,126,000 | 2,069,000 | 5,174,000 |
| TOTAL | $32,085,000 | $26,287,000 | $27,430,000 | $28,682,000 | $23,977,000 |
| Non-Current Assets | |||||
| PPE Net | 13,727,000 | 13,499,000 | 12,633,000 | 12,029,000 | 11,352,000 |
| Investments And Advances | 0 | 0 | 6,945,000 | 0 | 0 |
| Intangibles | 21,563,000 | 21,850,000 | 21,249,000 | 21,106,000 | 21,057,000 |
| Other Non-Current Assets | 16,024,000 | 14,682,000 | 7,195,000 | 15,119,000 | 14,235,000 |
| TOTAL | $51,314,000 | $50,031,000 | $48,022,000 | $48,254,000 | $46,644,000 |
| Total Assets | $83,399,000 | $76,318,000 | $75,452,000 | $76,936,000 | $70,621,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,559,000 | 5,731,000 | 5,117,000 | 6,576,000 | 6,819,000 |
| Accounts payable and accrued liabilities | 3,251,000 | 3,007,000 | 3,018,000 | 2,725,000 | 2,509,000 |
| Other current liabilities | 7,873,000 | 8,318,000 | 6,787,000 | 8,200,000 | 6,652,000 |
| TOTAL | $19,683,000 | $17,056,000 | $16,641,000 | $17,501,000 | $17,663,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,172,000 | 748,000 | 677,000 | 667,000 | 632,000 |
| Other Non-Current Liabilities | 9,928,000 | 9,242,000 | 4,263,000 | 9,272,000 | 8,654,000 |
| TOTAL | $12,111,000 | $9,996,000 | $9,415,000 | $9,942,000 | $9,294,000 |
| Total Liabilities | $31,794,000 | $27,052,000 | $26,056,000 | $27,443,000 | $26,957,000 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 990,000 | N/A | N/A |
| Retained earnings | N/A | N/A | 48,408,000 | N/A | N/A |
| Other shareholders' equity | 51,605,000 | 49,266,000 | 173,000 | 49,493,000 | 43,664,000 |
| TOTAL | $51,605,000 | $49,266,000 | $49,396,000 | $49,493,000 | $43,664,000 |
| Total Liabilities And Equity | $83,399,000 | $76,318,000 | $75,452,000 | $76,936,000 | $70,621,000 |